FindTrial
Sign In

Clinical observation of changes in ovarian reserve function in female patients with hematological malignances after chemotherapy or allogeneic hematopoietic stem cell transplantation

Clinical observation of changes in ovarian reserve function in female patients with hematological malignances after chemotherapy or allogeneic hematopoietic stem cell transplantation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100051035
Enrollment
Unknown
Registered
2021-09-10
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hematological malignances

Interventions

case series:no intervention

Sponsors

The First Affiliated Hospital of University of Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
6 Years to 49 Years

Inclusion criteria

Inclusion criteria: 1.Female patients aged 14-49 with newly diagnosed acute leukemia and lymphoma in our department; 2.Female patients aged 6-49 years undergoing HSCT in our department.

Exclusion criteria

Exclusion criteria: 1.Women of childbearing age who have undergone a previous hysterectomy or oophorectomy 2.Current diagnosis or treatment for a malignancy other than acute leukemia or lymphoma 3.Pre-existing clearly diagnosed endocrine system disease or connective tissue disease, currently receiving treatment 4.Previous recurrent menstrual cycle disorders or on oral contraceptives or hormone replacement therapy

Design outcomes

Primary

MeasureTime frame
ovarian reserve function;—

Countries

China

Contacts

Public ContactZhu Xiaoyu

The First Affiliated Hospital of University of Science and Technology of China

xiaoyuz@ustc.edu.cn+86 15255456091

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026